Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Serial FES PET Imaging for Endocrine-Targeted Therapy Evaluation
NCT02149173Terminated
- Sponsor
- University of Washington
- Start
- Sep 2010
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of fluoroestradiol f 18 in breast cancer, sponsored by University of Washington. Primary endpoints: Change in F-18 16 Alpha-fluoroestradiol (FES) Standardized Uptake Value (SUV), F-18 16 Alpha-fluoroestradiol (FES) Uptake and 1 more. Started Sep 2010; status: terminated.
02
Drugs
fluoroestradiol f 18
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02149173.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02149173.